DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+10.83%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.99B
AUM Growth
+$2.99B
(-2.3%)
Cap. Flow
-$245M
Cap. Flow
% of AUM
-8.2%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
154
New
30
Increased
26
Reduced
34
Closed
30
Top Buys
| 1 |
Viatris
VTRS
|
$58.4M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$56.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$38.2M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$35.8M |
| 5 |
Galapagos
GLPG
|
$33.1M |
Top Sells
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$446M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
Adverum Biotechnologies
ADVM
|
$85.8M |
| 4 |
BLUE
bluebird bio
BLUE
|
$51.3M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$27.7M |
Sector Composition
| 1 | Healthcare | 71.13% |
| 2 | Financials | 3.44% |
| 3 | Technology | 0.52% |
| 4 | Industrials | 0% |
